John W Childs sold $10.7M of Veradermics (MANE)

Executed Aug 12, disclosed Aug 14, 2 days later.

Value, as filed

$10.7M

100,000 sh across 3 lots

Executed

Aug 12

the trade date, as filed

Disclosed

Aug 14

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JC John W Childs Director profile →

John W Childs (Director) filed 5 Form 4 reports in the trailing twelve months (4 purchases, 1 sale, 2 filed past the two-business-day deadline), most often in BHVN. Across 2 priced purchase filings, the average 21-session return was +37.0% from execution and +27.3% from disclosure (delay-adjusted; derived). The largest single filing was $25.0M of BHVN (3,333,333 sh × $7.50, as filed), executed Nov 13 2025.

The name

MANE

Veradermics, Incorporated MANE · Healthcare · 10 filings in 24 months ticker →

Healthcare · Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthe…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by John W Childs in MANE

MANEPURCHASE Veradermics, Incorporated $5.0M
294,117 sh × $17.00
Exec Feb 5
Filed Feb 27 · 4:44 PM ET † MANEPURCHASE Veradermics, Incorporated $5.0M
294,117 sh × $17.00
Exec Feb 5
Filed Feb 5 · 7:04 PM ET